A new pill may give a different way to treat type‑2 diabetes and obesity. Early tests show it can lower blood sugar and help the body burn fat without making people feel hungry or lose muscle.
How It Differs From Existing Injections
Popular drugs like Ozempic are injections that tell the brain to eat less. This new medicine works inside the muscles instead. It does not try to stop hunger. The pill improves how the body handles sugar and how much fat is stored, while keeping muscle safe.
First Human Test Looks Positive
In a small Phase I trial, 48 healthy volunteers and 25 people with type‑2 diabetes took the tablet. All participants tolerated it well and showed signs of better sugar control.
"Our results suggest we can improve metabolism without losing muscle," said researcher Tore Bengtsson. Muscles matter a lot for both diabetes and overall lifespan.
Designed to Activate Muscle Metabolism
The drug is built around a lab‑made molecule called a β2‑agonist. Scientists changed it so it turns on important signals in muscle cells but does not over‑stimulate the heart, a problem that stopped similar drugs before.
"This pill could be a very important new treatment for diabetes and obesity," said Shane C. Wright. "It helps people lose weight healthily and does not require injections."
Can Be Used Alone or With Other Medicines
Because it works differently from GLP‑1 drugs, the pill might be used by itself or together with existing treatments. Researchers think this flexibility could help many patients.
Next Steps
The company Atrogi AB will run a larger Phase II trial to see if the benefits hold true for more people with diabetes or obesity.
Collaboration and Funding
The study involved scientists from several universities in Sweden, Denmark, Australia and Canada. Funding came from the Swedish Research Council, the Swedish Society for Medical Research and the Novo Nordisk Foundation.